HIV-1 Encephalopathy and AIDS Dementia Complex: Multimedia

References

1. Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, et al. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology. Decemeber 2009;73(23):1982-7. [Medline].

2. American Psychiatric Association. Practice Guideline for the Treatment of Patients with HIV/AIDS. In: Practice Guidelines for the Treatment of Psychiatric Disorders. 2004:137-248.

3. Antinori A, Giancola ML, Grisetti S, et al. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS. Sep 27 2002;16(14):1867-76. [Medline].

4. Bradley WG, Daroff RB, Fenichel GM. Neurologic manifestations of human immunodeficiency virus infection in children. In: Neurology in Clinical Practice. 2. 2004:1603-1611.

5. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. Feb 1999;52(3):607-13. [Medline].

6. Chiriboga CA, Fleishman S, Champion S, et al. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr. Mar 2005;146(3):402-7. [Medline].

7. de Gans J, Portegies P. Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clin Neurol Neurosurg. 1989;91(3):199-219. [Medline].

8. Dore GJ, McDonald A, Li Y, et al. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. Jul 4 2003;17(10):1539-45. [Medline].

9. Ernst T, Chang L, Jovicich J, et al. Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology. Nov 12 2002;59(9):1343-9. [Medline].

10. Gendelman HE, Lipton SA, Epstein L. The Neurology of AIDS. New York: Chapman & Hall;1998.

11. Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol. Jan 2005;5(1):69-81. [Medline].

12. Manji H, Miller R. The neurology of HIV infection. J Neurol Neurosurg Psychiatry. Mar 2004;75 Suppl 1:i29-35. [Medline].

13. McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. Dec 2004;157(1-2):3-10. [Medline].

14. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology. Nov 1993;43(11):2245-52. [Medline].

15. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis. Dec 1 2002;186 Suppl 2:S193-8. [Medline].

16. Nath A, Anderson C, Jones M, et al. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol. 2000;14(3):222-7. [Medline].

17. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986;19:525-535. [Medline].

18. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19:517-524. [Medline].

19. Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol. May 2006;61(5):393-401. [Medline].

20. Pajeau AK, Roman GC. HIV encephalopathy and dementia. Psychiatr Clin North Am. Jun 1992;15(2):455-66. [Medline].

21. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis. Nov 1988;158(5):1079-83. [Medline].

22. Price RW, Perry SW. HIV, AIDS, and the Brain. New York: Raven Press;1994. [Medline].

23. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. Jan 23 2001;56(2):257-60. [Medline].

24. Sacktor N, Nakasujja N, Skolasky R. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology. Jul 25 2006;67(2):311-4. [Medline].

25. Said G, Saimont AG, Lacroix C. Neurological Complications of HIV and AIDS. Philadelphia: WB Saunders; 1998.

26. Schutzer SE, Brunner M, Fillit HM, Berger JR. Autoimmune markers in HIV-associated dementia. J Neuroimmunol. May 2003;138(1-2):156-61. [Medline].

27. Sevigny JJ, Albert SM, McDermott MP. An evaluation of neurocognitive status and markers of immune activation aspredictors of time to death in advanced HIV infection. Arch Neurol. 2007;64(1):97-102. [Medline].

28. SMART study group, El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. Nov 30 2006;355(22):2283-96. [Medline].

29. Thomas FP, Chalk C, Lalonde R, et al. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J Virol. Nov 1994;68(11):7099-107. [Medline].

30. Wong MH, Robertson K, Nakasujja N. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology. Jan 30 2007;68(5):350-5. [Medline].

Further Reading

Keywords

AIDS dementia complex, ADC, HIV-1–associated cognitive/motor complex, AIDS encephalopathy, HIV encephalopathy, subacute HIV encephalitis, HIV-associated dementia complex, AIDS-related dementia, HIV dementia, acquired immunodeficiency syndrome, AIDS, human immunodeficiency virus, HIV, minor cognitive motor disorder, MCMD, highly active antiretroviral therapy, HAART

Contributor Information and Disclosures

Author

Niranjan N Singh, MD, DNB, Assistant Professor of Neurology, University of Missouri Columbia
Niranjan N Singh, MD, DNB is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Coauthor(s)

Sofia Yahya, MD, Former Psychiatrist, East Coast Center for Psychiatry
Sofia Yahya, MD is a member of the following medical societies: American Psychiatric Association
Disclosure: Nothing to disclose.

Mandeep Garewal, MD, Director, Ocean Sleep Disorders Center, Neurology Associates of Ormond Beach
Mandeep Garewal, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, and American Society of Neuroimaging
Disclosure: Nothing to disclose.

Florian P Thomas, MD, MA, PhD, Drmed,, Director, Spinal Cord Injury Service, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Director, Neuropathy Association Center of Excellence, Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Florian P Thomas, MD, MA, PhD, Drmed, is a member of the following medical societies: American Academy of Neurology, American Neurological Association, American Paraplegia Society, and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

Medical Editor

Ronald A Greenfield, MD, Professor, Department of Internal Medicine, Section of Infectious Diseases, University of Oklahoma College of Medicine
Ronald A Greenfield, MD is a member of the following medical societies: American College of Physicians, American Federation for Medical Research, American Society for Microbiology, Central Society for Clinical Research, Infectious Diseases Society of America, Medical Mycology Society of the Americas, Phi Beta Kappa, Southern Society for Clinical Investigation, and Southwestern Association of Clinical Microbiology
Disclosure: Pfizer Honoraria Speaking and teaching; Gilead Honoraria Speaking and teaching; Ortho McNeil Honoraria Speaking and teaching; Wyeth Honoraria Speaking and teaching; Abbott Honoraria Speaking and teaching; Astellas Honoraria Speaking and teaching; Cubist  Speaking and teaching

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale
Richard J Caselli, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, American Neurological Association, and Sigma Xi
Disclosure: Nothing to disclose.